WO2002062997A1 - Novel protein and use thereof - Google Patents
Novel protein and use thereof Download PDFInfo
- Publication number
- WO2002062997A1 WO2002062997A1 PCT/JP2002/000884 JP0200884W WO02062997A1 WO 2002062997 A1 WO2002062997 A1 WO 2002062997A1 JP 0200884 W JP0200884 W JP 0200884W WO 02062997 A1 WO02062997 A1 WO 02062997A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- screening
- inhibiting
- usable
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
It is intended to provide a novel secretory protein. More specifically, a novel secretory protein, its peptide fragment or its salt; a process for producing this protein; drugs containing this protein, etc.; an antibody against the above protein; a method/a kit for screening a compound or its salt capable of promoting or inhibiting the activity of the above protein; compounds obtained by the screening; drugs containing these compounds, etc. The above-described protein, its peptide fragment, etc. are usable as, for example, regenerating agents to be used after taking out damaged tissues or diagnostics for cancer. The above antibody is usable in quantifying the above protein in a liquid sample, etc. The above protein is also useful as a remedy for screening a compound capable of promoting or inhibiting the activity of the protein.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001028655 | 2001-02-05 | ||
| JP2001-28655 | 2001-02-05 | ||
| JP2001040534 | 2001-02-16 | ||
| JP2001-40534 | 2001-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002062997A1 true WO2002062997A1 (en) | 2002-08-15 |
Family
ID=26608940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2002/000884 Ceased WO2002062997A1 (en) | 2001-02-05 | 2002-02-04 | Novel protein and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2002062997A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999031241A1 (en) * | 1997-12-17 | 1999-06-24 | Immunex Corporation | Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
-
2002
- 2002-02-04 WO PCT/JP2002/000884 patent/WO2002062997A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999031241A1 (en) * | 1997-12-17 | 1999-06-24 | Immunex Corporation | Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004009622A3 (en) | Protein complexes of cellular networks underlying the development of cancer and other diseases | |
| WO2000001845A3 (en) | Method for early diagnosis of carcinomas | |
| WO2004063704A3 (en) | Vitamin d assay | |
| WO2004094460A3 (en) | Polypeptides related to natriuretic peptides and methods of their identification and use | |
| WO2005021841A3 (en) | Methods and apparatus for rapid crystallization of biomolecules | |
| WO2005052542A3 (en) | Method and composition useful for determining fk 506 | |
| WO2003078600A3 (en) | Human monoclonal antibodies to influenza m2 protein and methods of making and using same | |
| WO2004094459A3 (en) | Polypeptides related to natriuretic peptides and methods of their identification and use | |
| WO2003016464A3 (en) | Cancer specific oligosaccharide sequences and use thereof | |
| WO2001096373A3 (en) | Fluorescent timer proteins and methods for their use | |
| WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
| AU7410600A (en) | Method for the determination of substances using the evanescence field method | |
| EP1544293A4 (en) | Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same | |
| CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
| WO2005033330A3 (en) | Fluorescent probes for use in protein kinase inhibitor binding assay | |
| WO2004069860A3 (en) | Isg15-conjugated proteins | |
| WO2002062997A1 (en) | Novel protein and use thereof | |
| WO2002026929A3 (en) | Kini-3 motor protein and methods for its use | |
| AUPS064202A0 (en) | Improved method for the analysis of nucleic acid samples | |
| WO2004085618A3 (en) | Method of screening for target ligands | |
| WO2002062944A3 (en) | Novel physiologically active peptide and use thereof | |
| WO2006108051A3 (en) | Compositions and methods relating to alzheimer's disease | |
| WO2000064469A3 (en) | Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds | |
| EP1593691A4 (en) | Method of acquiring human monoclonal antibody inhibiting cancer cell proliferation | |
| WO2004031242A3 (en) | Protein complexes involved in neurological diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |